Harvard Bioscience Inc. — Short Positions & Disclosures
Regulatory net short position disclosures over time
As of 16 Apr 2026, 1 institution has disclosed net short positions in Harvard Bioscience Inc. totalling 0.53% of issued share capital. The largest disclosed short seller is Squarepoint Ops LLC at 0.53%. Positions are publicly disclosed under UK FCA rules once they reach or exceed 0.5% of issued share capital.
Last updated
Harvard Bioscience Inc. | Short Positions Over Time
US4169062043Short positions must be disclosed when they reach or exceed 0.5% of issued share capital.
Current Short Positions
All disclosed positions as of the latest report date
| Holder | Net Short % | Position Date | Position Value |
|---|---|---|---|
Squarepoint Ops LLC | 0.53% | 16 Apr 2026 | Locked |
Data source: UK Financial Conduct Authority short position disclosures, plus equivalent disclosures from EU regulators (BaFin, CONSOB, AFM, Finansinspektionen). View FCA short selling rules.
Net short percentage represents the percentage of issued share capital held short. Positions must be publicly disclosed when they reach or exceed the 0.5% regulatory threshold. Read the methodology.